Kiora Pharmaceuticals (KPRX) Misses Q2 EPS by 53c
Tweet
Share
E-mailKiora Pharmaceuticals (NASDAQ: KPRX) reported Q2 EPS of ($0.53).
For earnings history and earnings-related data on Kiora Pharmaceuticals (KPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- DSM-Firmenich AG (DSFIR:NA) PT Raised to EUR98 at Deutsche Bank
- Morgan Stanley Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
